Home › Funds › UBS Group AG › ELEV
UBS Group AG position in ELEV
ELEVATION ONCOLOGY INC
Latest position (Q2 2025)201.66K sh
Reported value held$74.01K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 2.42K | $15.00K | New |
| Q4 2022 | 1.78K | $1.69K | New |
| Q1 2023 | 100 | $190 | Reduce |
| Q2 2023 | 16.08K | $24.44K | Add |
| Q3 2023 | 124.56K | $82.58K | Add |
| Q4 2023 | 128.47K | $68.99K | Add |
| Q1 2024 | 122.56K | $628.76K | Reduce |
| Q2 2024 | 15.83K | $42.74K | Reduce |
| Q3 2024 | 42.59K | $25.55K | Add |
| Q4 2024 | 88.63K | $49.90K | Add |
| Q1 2025 | 116.45K | $30.16K | Add |
| Q2 2025 | 201.66K | $74.01K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.